Usa Coronavirus Covid-19 hospital Usa

FDA OKs first antiviral pill for COVID

Reading now: 378

The federal Food and Drug Administration has granted emergency use authorization of Paxlovid (nirmatrelvir plus ritonavir), the first antiviral pill for the treatment of COVID-19.

The December 22 authorization comes just in time, as the coronavirus Omicron variant is spreading rapidly throughout the United States, but supplies will initially be limited. "This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and [it] promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19," Dr.

Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, stated in a news release. Paxlovid, from Pfizer, is

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News